Historical record - last NADAC effective date: 7/18/2018
Product Information
DANTROLENE SODIUM 25 MG CAP is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.7194 per EA under NDC 00115441103. Its NADAC has been published 250 times since Nov 28, 2013.
FDA first approved this application on Mar 1, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115441103
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
7/18/2018
Active Ingredients
DANTROLENE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA076856FDA Approved
3/1/2005
TE Code
AB
On Market Since
3/1/2005
Pharmacological Classes
Price Statistics
The NADAC for DANTROLENE SODIUM 25 MG CAP has been published 250 times since Nov 28, 2013, and over the history we have for it it has declined 11.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7194 per EA |
|---|---|
| All-time high | $0.8948 (Aug 10, 2016) |
| All-time low | $0.5121 (Aug 23, 2017) |
| Median price | $0.7818 |
| Average price | $0.7550 |
| Largest weekly change | -24.7% (Aug 23, 2017) |
| Weeks tracked | 250 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-11.2%
Last surveyed Sep 5, 2018 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 43% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dantrolene Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Skeletal Muscle Relaxant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DANTROLENE SODIUM 25 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DANTROLENE SODIUM 25 MG CAP, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.7194 per EA (NDC 00115441103), effective Sep 5, 2018.
How has the price of DANTROLENE SODIUM 25 MG CAP changed over time?
Over the history we have for it, the NADAC for DANTROLENE SODIUM 25 MG CAP has declined 11.2%. It has been tracked across 250 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DANTROLENE SODIUM 25 MG CAP?
Since Nov 28, 2013, the NADAC for DANTROLENE SODIUM 25 MG CAP has ranged from a low of $0.5121 (Aug 23, 2017) to a high of $0.8948 (Aug 10, 2016), with a median of $0.7818 per EA.
Are there cheaper alternatives to DANTROLENE SODIUM 25 MG CAP?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DANTROLENE SODIUM 25 MG CAP, is $0.4088 per EA — about 43% below DANTROLENE SODIUM 25 MG CAP.
Who manufactures DANTROLENE SODIUM 25 MG CAP?
DANTROLENE SODIUM 25 MG CAP (NDC 00115441103) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.